Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Matteelli (Brescia, Italy). XDR-TB and MDR-TB in Europe: still a challenge. Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcomes for multidrug-resistant tuberculosis (MDR-TB) patients in Africa Source: Annual Congress 2011 - Multidrug-resistant tuberculosis Year: 2011 Linezolid in the treatment of patients with MDR TB and XDR TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 XDR-TB in South Africa: from clinical management to public-health action Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management Year: 2011 Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Why did they get XDR TB ? Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Facilities for treating multidrug-resistant tuberculosis (MDRTB) in Europe Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 Active pharmacovigilance for multidrug-resistant tuberculosis patients treated with Linezolid, Belarus – 2014-2015 Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in Romania Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Trend in TB control in Republic of Moldova: High MDRTB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 The global risk of dying from multidrug-resistant tuberculosis (MDR-TB) Source: International Congress 2014 – Tuberculosis epidemiology: novel features Year: 2014 MDR-TB and XDR-TB: drug resistance and treatment outcomes Source: Eur Respir J 2009; 34: 778 Year: 2009 Evaluation of failures treated with linezolid-containing regimen for extensively drug-resistant tuberculosis (XDR-TB) Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 XDR-TB: Indian perspective Source: Eur Respir J 2007; 30: 178-179 Year: 2007 Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013